First test of new spinal injury drug begins in humans
NCT ID NCT05524103
Summary
This was an early-stage study to check the safety of a new drug called ALMB-0166 in people with a recent spinal cord injury. It involved 24 patients who received either the drug or a placebo. The main goal was to see if the drug was safe and to understand how the body absorbs and processes it.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE SPINAL CORD INJURY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Peking University Third Hospital
Beijing, Beijing Municipality, China
-
Peking University Third Hospital Medical Science Research Ethic Committee
Beijing, Beijing Municipality, 100191, China
Conditions
Explore the condition pages connected to this study.